Hepatocyte-specific S100a8 and S100a9 transgene expression in mice causes Cxcl1 induction and systemic neutrophil enrichment
- Lars Wiechert1,
- Julia Németh1,
- Tobias Pusterla1,
- Christine Bauer1,
- Aurora De Ponti1,
- Sandra Manthey2,
- Silke Marhenke3,
- Arndt Vogel3,
- Ursula Klingmüller2,
- Jochen Hess†4, 5Email author and
- Peter Angel†1
© Wiechert et al.; licensee BioMed Central Ltd. 2012
Received: 10 August 2012
Accepted: 7 December 2012
Published: 15 December 2012
Calprotectin consists of the Ca2+-binding proteins S100a8 and S100a9 that are induced in epithelial cells in response to tissue damage and infection. Both proteins are also secreted by activated innate immune cells and numerous studies demonstrate their crucial role in pathological conditions of acute and chronic inflammation.
Here, we established a conditional mouse model with simultaneous S100a8 and S100a9 transgene expression in hepatocytes (TgS100a8a9 hep ) under the control of doxycycline to unravel the role of epithelial-derived Calprotectin on tissue homeostasis and inflammation. TgS100a8a9 hep mice displayed a significant enrichment of neutrophils in peripheral blood and tissues with high blood content. Interestingly, Cxcl1 transcription was significantly induced in the liver of TgS100a8a9 hep mice and primary hepatocytes derived thereof as compared to Control mice, accompanied by an increase of Cxcl1 serum levels. However, expression of other chemokines with a known function in neutrophil mobilization from the bone marrow, e.g. Csf3 and Cxcl2, was not altered. Doxycycline treatment of TgS100a8a9 hep mice reduced Cxcl1 expression in the liver and resulted in normal numbers of neutrophils.
In summary, our data demonstrate for the first time that hepatocyte-specific S100a8 and S100a9 expression induces a systemic mobilization of neutrophils by a specific activation of Cxcl1 transcription in the liver.
KeywordsCalgranulins Calprotectin Hepatocytes Neutrophils Chemokines Immune cell mobilization
S100 proteins are a family of small Ca2+-binding proteins which share a broad spectrum of functions including regulation of enzyme activity, Ca2+-homeostasis, and interaction with components of the cytoskeleton. Belonging to this family, S100A8 and S100A9 also known as migration inhibitory factor-related protein 8 (MRP8) and 14 (MRP14) are low molecular weight proteins of 8 kDa and 14 kDa, respectively, and were initially described as proteins expressed and released by infiltrating phagocytes[2, 3]. S100A8 and S100A9 form preferably heterodimers also known as Calprotectin (S100A8/A9) whereas monomers and homodimers could not be detected in isolated granulocytes and monocytes. Although expression of S100A8/A9 under physiologic conditions is restricted to cells of myeloid origin including circulating neutrophils, monocytes, and eosinophils[5, 6], strong induction of S100A8/A9 was detected in epithelial and endothelial cells under inflammatory and stress conditions. Furthermore, marked expression of S100A8/A9 was found in many tumors of epithelial origin including lung, breast, gastric, colorectal and prostate cancer. These data strongly imply important functions of S100A8/A9 under conditions of tissue damage and inflammation. Accordingly S100A8/A9 is strongly induced in a broad variety of different chronic inflammatory disorders including rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, cystic fibrosis, arthritis, and psoriasis. S100A8/A9 is able to support an inflammatory response via both intra- and extracellular mechanisms. In fact, intracellular S100A8/A9 has been shown to facilitate leukocyte trafficking through the transendothelial membrane via microtubule reorganization, upregulation of CD11b, as well as increase in the binding affinity of CD11b to the endothelial expressed integrin ICAM-1. Moreover S100A8/A9 is able to boost the inflammatory response by promotion of NADPH oxidase activity and production of ROS in phagocytes and epithelial cells. After secretion at the site of insult by epithelial and innate immune cells, S100A8/A9 directly acts as a chemoattractant for leukocytes, as demonstrated both in vitro and in vivo. Importantly, S100A8/A9 is known to amplify pro-inflammatory signals, as it is able to induce the production and release of many cytokines and chemokines by epithelial and innate immune cells, e.g. CXCL1, CXCL2, IL-6, and TNF. In this context S100A8/A9 was shown to promote pre-metastatic niche formation in the lungs of tumor-bearing mice[16, 17]. Moreover, S100A8/A9 can promote its own expression by a feed-forward loop.
In vivo studies highlighted a crucial role for S100a8/a9 in the promotion of inflammation and inflammation-induced carcinogenesis by using S100a9 -/- animals in models of antigen-induced arthritis and colon carcinogenesis, respectively. However these studies focused on the role of myeloid-derived S100a8/a9. In contrast, no causal link between epithelial-derived S100a8/a9 and the establishment of chronic inflammation and subsequent tumor-development has been demonstrated yet. Strong experimental evidence indicates that S100A8/A9 overexpression in hepatocytes is associated with liver carcinogenesis as epidemiological studies showed a profound correlation of both proteins with high grade hepatocellular carcinoma in humans. Moreover, our group demonstrated a strong increase in S100a8/a9 in the Mdr2 -/- model of inflammation-induced carcinogenesis in a NF-κB dependent manner. Interestingly, elevated S100a8/a9 levels protected hepatocellular carcinoma cell lines from TNF-mediated apoptosis and promoted the production of ROS. Moreover, liver injury induced by partial hepatectomy lead to induction of S100a8/a9 expression in hepatocytes, suggesting a role in liver regeneration. Hitherto, we do not know whether the impact on pathological conditions of liver injury and carcinogenesis is mediated by well-known functions of S100a8/a9 on the amplification of pro-inflammatory signals, including immune cell recruitment and activation[15, 23], because informative in vivo studies are still missing.
In contrast to other in vivo studies focusing on the function of heavily elevated systemic S100a8/a9 levels in settings of acute or chronic inflammation[18, 24], we have established a conditional mouse model under the control of doxycycline to specifically investigate the effects of local S100a8/a9 overexpression without inducing a pathologic situation. In the present study we show that the simultaneous expression of S100a8 and S100a9 transgenes in hepatocytes leads to a constant homeostatic mobilization of neutrophils from the bone marrow via local induction of Cxcl1 expression. Importantly, the enrichment of the neutrophils occurs without activation and therefore hints to a so far unknown mechanism by which epithelial-derived S100a8/a9 may increase the surveillance capacity of an organism by innate immune cells.
Conditional and hepatocyte-specific transgene expression in TgS100a8a9 hep mice
TgS100a8a9 hep mice develop a systemic enrichment in neutrophils
IHC staining of liver sections with specific antibodies for S100a8 and S100a9, respectively, well-characterized markers for granulocytes and circulating monocytes[3, 27], and subsequent quantification of S100a8 and S100a9 positive immune cells confirmed a significant increase of this subpopulation of immune cells (Figure2C, data not shown). Indeed, comparison of the relative amount of Gr1- and S100a9-positive cells in the liver of Control and TgS100a8a9 hep mice revealed a high correlation coefficient (R2=0.95). Moreover, qRT-PCR analysis with cDNA of liver samples and primers recognizing selectively endogenous but not transgenic transcripts confirmed increased S100a8 and S100a9 expression in TgS100a8a9 hep compared to Control mice (Additional file2: Figure S2D). In summary, our data supported a causal link between transgene expression and the accumulation of a distinct Gr1-positive immune cell subpopulation of the monocyte lineage in the liver of TgS100a8a9 hep mice.
To investigate whether the accumulation of this immune cell subpopulation increased with age or caused an alteration in liver architecture, liver sections of six month-old Control and TgS100a8a9 hep mice were stained with HE and for Gr1-positive cells by IHC staining. A substantial increase in Gr1-positive cells was still detectable in liver sections of six month-old TgS100a8a9 hep as compared to Control mice and no obvious difference was found when compared to younger TgS100a8a9 hep animals (Additional file3: Figure S3).
Systemically enriched neutrophils in TgS100a8a9 hep mice are not activated
Altered expression of the chemokine Cxcl1 in the liver of TgS100a8a9 hep mice
To address the question whether hepatocytes are the source of increased Cxcl1 transcript levels in TgS100a8a9 hep mice, livers of Control and TgS100a8a9 hep mice (n=3 each) were perfused with collagenase and the cell suspension was cultivated in vitro for 24 hours to obtain primary hepatocytes. One aliquot of the cell suspension was directly taken after enzymatic digestion and a significant increase in Cxcl1 transcript levels in the liver of TgS100a8a9 hep mice was confirmed by qRT-PCR (Additional file6: Figure S6A). Subsequent qRT-PCR analysis with cDNA from primary hepatocytes, which were cultured in vitro for 24 hours revealed a strong expression in S100a8 and S100a9 transgenes in TgS100a8a9 hep hepatocytes and a significant increase in the expression of Cxcl1 in TgS100a8a9 hep as compared to Control hepatocytes, whereas Cxcl2 and Csf1 were not affected (Figure5B and Additional file6: Figure S6B). These data strongly suggest that hepatocytes are the main source of increased Cxcl1 transcription in the liver of TgS100a8a9 hep mice.
Finally, we analyzed serum and liver samples of Control and TgS100a8a9 hep mice by enzyme-linked absorbent immunoassays (ELISA) for Cxcl1, Cxcl2, and Csf3 protein levels. Substantial levels of Cxcl1 and Csf3 were measured in both groups, whereas only low amounts were detected for Cxcl2 (Figure5C). We found no major difference in Cxcl2 and Csf3 protein levels, but in accordance with the qRT-PCR data, Cxcl1 protein levels were significantly increased in TgS100a8a9 hep as compared to Control mice (Figure5C and Additional file7: Figure S7).
Enhanced Cxcl1 expression and neutrophil enrichment in TgS100a8a9 hep mice depends on transgene expression
Taken together our data confirmed that the increase in Cxcl1 expression, which is accompanied by systemic enrichment of neutrophils in TgS100a8a9 hep mice critically depends on conditional S100a8 and S100a9 transgene expression in the liver.
The p38 MAPK pathway is inhibited in TgS100a8a9 hep hepatocytes and represents a negative regulator of Cxcl1 expression
A broad range of experimental studies demonstrate a direct link between S100a8/a9 protein expression and acute and chronic inflammation as well as inflammation-induced carcinogenesis. In fact, S100a8/a9 is involved in several steps of the inflammatory response including leukocyte differentiation and chemoattraction, transendothelial migration, activation of immune and epithelial cells, and the induction of pro-inflammatory mediators. Thereby S100a8/a9 might promote an inflammatory feed-forward loop, which facilitates the transition to a chronic inflammation. An established chronic inflammation strongly increases the likelihood of pathologic conditions such as tumor formation and is even considered as a hallmark of carcinogenesis. Indeed in vivo studies with S100a9 -/- animals highlighted a crucial role for S100a8/a9 in the promotion of inflammation and inflammation-induced carcinogenesis in models of antigen-induced arthritis and colon carcinogenesis, respectively[18, 19]. However these studies focused on the role of S100a8/a9 in the differentiation and function of myeloid-derived S100a8/a9. In contrast, no causal connection of epithelial-derived S100a8/a9 and the initiation and maintenance of a chronic inflammation and subsequent tumor-development have been demonstrated yet.
In order to investigate the role of epithelial-derived S100a8/a9 in liver homeostasis, we generated TgS100a8a9 hep mice with conditional and hepatocyte-specific S100a8 and S100a9 expression. The initial characterization revealed persistent transgene expression in liver. Furthermore the conditional tgS100a8/a9 expression in TgS100a8a9 hep mice was confirmed via doxycycline treatment. Additionally, transgenic protein was detected in purified whole liver lysates from TgS100a8a9 hep mice, whereas the serum levels of total S100a8/a9 were unchanged in TgS100a8a9 hep mice compared to Controls. In summary the TgS100a8a9 hep mice showed conditional and hepatocyte-specific expression of tgS100a8/a9 transcripts, which was not sufficient to reach a systemic increase of total S100a8/a9. Interestingly, all animal models, which were used so far to show S100a8/a9-dependent immune cell recruitment and activation accompanied by pathologic conditions were characterized by a strong S100a8/a9 overexpression[14, 16, 23, 24]. In contrast, the use of the TgS100a8a9 hep mouse model enabled for the first time a detailed analysis of physiological and pathophysiological alterations in settings of low and locally restricted S100a8/a9 induction in vivo.
S100a8/a9 has been shown to act as a potent chemoattractant and activator for monocytes and neutrophils[14, 21, 23]. Therefore, tgS100a8/a9 expression might be expected to induce pathologic changes affecting liver homeostasis. However, TgS100a8a9 hep mice showed neither obvious differences in liver architecture and liver damage nor changes in the number of resident Kupffer cells. Interestingly, TgS100a8a9 hep animals developed a significant enrichment of Gr1-positive immune cells in the liver as compared to Control mice. Further characterization showed that this immune cell subpopulation was positive for endogenous S100a8 and S100a9 proteins and transcripts, and importantly, aged TgS100a8a9 hep animals exhibited a comparable enrichment of this specific immune subpopulation, supporting the existence of a constitutive signal in TgS100a8a9 hep mice, which leads to a sustained increase of these cells. Of note, the Gr1-positive subpopulation did not infiltrate into the liver parenchyma but rather accumulated in the blood and therefore appeared in the sinusoids of the liver. Therefore we hypothesized a systemic accumulation of Gr1-positive cells in TgS100a8a9 hep mice. Indeed, qRT-PCR analysis revealed an elevation of endogenous S100a8/a9 transcripts, which was used as a surrogate marker for the affected subpopulation, also in other perfused tissues including brain, kidney, and heart. This further supported the hypothesis of a systemic enrichment in TgS100a8a9 hep mice, which was further confirmed by blood counts and flow cytometric analysis on peripheral blood samples. Although spleen is a highly perfused organ, it serves as marginating pool for granulocytes, ensuring rapid mobilization of innate immune cells upon infection and inflammation to facilitate an immediate inflammatory response. Consequently, the overall amount of S100a8/a9 is very high and the difference due to the enriched population in TgS100a8a9 hep mice was not detectable.
Neutrophils circulating in the blood stream under healthy conditions, serve as first defense line against pathogens, and represent key players in sterile inflammatory diseases by secreting a plethora of different pro-inflammatory mediators. Since the TgS100a8a9 hep mice developed no obvious pathological phenotype over time it was questioned whether the neutrophils were fully activated. Indeed, flow cytometric analysis on neutrophils of TgS100a8a9 hep mice revealed neither an increase in Cd11b expression nor ectodomain shedding of L-Selectin, which are well-known activation markers of neutrophils[31, 38]. Together, these data convincingly show that the enriched neutrophils in the TgS100a8a9 hep mice are not activated, and additional signals are missing to induce an acute and/or chronic inflammation.
Injection of high amounts of S100a8/a9 was shown to directly act as a chemoattractant for neutrophils and lead to tissue-specific recruitment but was also reported as an activator of neutrophils[14, 23]. Furthermore, a causal role for S100a8 in inducing myeloid cell migration has been demonstrated without further activation. However TgS100a8a9 hep mice showed a systemic enrichment of neutrophils without activation and site-specific recruitment. This argues for a so far unknown mechanism of S100a8/a9, which might be only visible under conditions when tgS100a8/a9 expression is locally restricted to the liver without potent systemic accumulation. Hence we assumed that a mechanism, which is implicated in regulation of circulating neutrophils under homeostasis, was affected in TgS100a8a9 hep mice resulting in elevated neutrophil levels. The number of circulating neutrophils is mainly regulated via a constant release from the bone marrow compartment. This homeostatic release is realized either by Csf3, which is able to interfere with the Cxcl12-Cxcr4 mediated neutrophil retention[33, 34, 38], or by Cxcl1 and Cxcl2, which directly act as chemoattractants for neutrophils via Cxcr2. Moreover, experimental evidence suggests that other factors e.g. Csf1 and Csf2 might be involved in neutrophil mobilization under homeostasis[40, 41]. Interestingly, only Cxcl1 was increased in the liver and serum of TgS100a8a9 hep compared to Control mice, whereas other factors were either not detectable or were not altered. Moreover, Cxcl1 was overexpressed in primary hepatocytes isolated from TgS100a8a9 hep mice, supporting that an increase in Cxcl1 expression is at least in part mediated by hepatocytes.
In line with our findings, recent reports demonstrated that administration of recombinant Cxcl1 in mice results in a three- to four-fold increase in the number of circulating neutrophils due to release from the bone marrow[34, 42]. Accordingly, transgenic mice overexpressing Cxcl1 in different tissues showed elevated numbers of circulating neutrophils. It is worth mentioning that also Cxcl1-induced neutrophils showed no signs of further activation in terms of Cd11b upregulation and L-Selectin shedding. On the other hand mice deficient for Cxcr2 displayed an abnormal retention of neutrophils in the bone marrow whereas the numbers of circulating neutrophils largely declined.
The expression of Cxcl1 is regulated by several transcription factors, including NF-κB, AP-1, and Stat3, which facilitate a rapid activation upon inflammatory stimulation. S100a8/a9 expressed by hepatocytes in TgS100a8a9 hep mice may be secreted in minor amounts and act in an autocrine manner via binding to Rage or Tlr4, both well established membrane receptors for extracellular S100a8/a9[19, 47]. Engagement of these receptors has been shown to induce relevant transcription factors for induced Cxcl1 transcription as well as their upstream signaling pathways, such as p38 and ERK1/2 MAPKs[48–50]. Western Blot analysis of primary hepatocytes revealed a substantial decrease in activation of the p38 MAPK pathway whereas other pathways were not altered. Inhibition of p38 activity was shown previously by our group and others in situations of intracellular S100a8/a9 expression[21, 51]. In contrast, extracellular S100a8/a9 rather lead to a positive regulation of p38[17, 51]. Together with the finding that S100a8/a9 serum levels are unchanged in TgS100a8a9 hep as compared to Control and increased Cxcl1 levels were observed in isolated hepatocytes our results point to an intracellular rather than an extracellular mode of action, how S100a8/a9 mediated Cxcl1 induction. Finally, inhibition of p38 MAPK lead to increased expression of Cxcl1 in primary hepatocytes by an as yet unknown mechanism indicating a role of p38 as a negative regulator for Cxcl1 expression under conditions without inflammatory stimuli.
TgS100a8a9 hep mice with conditional and hepatocyte-specific expression of S100a8 and S100a9 served as an useful tool to unravel a so far unknown function of calprotectin on the mobilization of neutrophils. Our new findings have a major impact on the current view, how calprotectin may influence acute and chronic inflammation under pathological conditions. Ichikawa et al. demonstrated in a model of colitis-associated carcinogenesis that myeloid-derived S100a8/a9 induces chemokine expression by tumor cells, including Cxcl1, which was associated with an accumulation of Cd11b+/Gr1+ immune cells. However, TgS100a8a9 hep mice revealed a neutrophil mobilization upon expression of S100a8/a9 in non-transformed epithelial cells (Figure8), and elucidated a complete new aspect of the role played by calprotectin in epithelial cells: S100a8/a9 may support an acute inflammatory response by increasing steady state levels of circulating neutrophils and thereby help to restore tissue homeostasis. However, under settings of sustained tissue damage the constitutive mobilization of neutrophils by a S100a8/a9-Cxcl1-dependent mechanism could enhance the risk for the development and maintenance of chronic inflammation.
Animals and animal work
Animals were maintained in a specific pathogen-free environment. All animal experiments were performed with age-matched male mice. The procedures for performing animal experiments were in accordance with the principles and guidelines of the Arbeitsgemeinschaft der Tierschutzbeauftragten in Baden-Württemberg and were approved by the German Regional Council in Karlsruhe.
TALap1 mice were described previously. In order to generate the TetOa8a 9 mouse line, a bidirectional Tet-inducible expression plasmid was cloned from the parental pBi-L (Clontech Laboratories) encoding S100a8-myc/his and S100a9-myc/his fusion constructs driven by Tet-responsive promoter. The linearized pBi-S100a8a9 construct was injected into blastocytes of C57B1/6 mice. Genomic integration was determined by Southern Blot analysis.
For the analysis TALap1 and TetOa8a9 single transgenic mice served as Control animals. For doxycycline treatment, 6 to 8 week-old animals received 10 μg/ml doxycycline 5% sucrose containing drinking water ad libitum for a period of 3 weeks. Primary mouse hepatocytes were isolated and cultured as described. Briefly, 8 week-old mice were anesthetized by intraperitoneal injection of 5 mg/100 mg body weight 10% ketamine hydrochloride and 1 mg/100 mg body weight 2% xylazine hydrochloride. After opening the abdominal cavity, the liver was perfused at 37°C with EGTA buffer (0.6% Glucose (w/v), 105 mM NaCl, 2.4 mM KCl, 1.2 mM KH2PO4, 26 mM Hepes, 490 μM L-Glutamine, 512 μM EGTA, 15% (v/v) amino acid solution, pH 8.3) via the portal vein for 5 min and subsequently for 5 min with Collagenase buffer (0.6% Glucose (w/v), 105 mM NaCl, 2.3 mM KCl, 1.2 mM KH2PO4, 25 mM Hepes, 490 μM L-Glutamine, 5.3 mM CaCl2, 12% (v/v) amino acid solution, 365 μg/ml collagenase type I-A, pH 8.3) until disintegration of the liver structure was observed. The liver capsule was removed, and the cell suspension was filtered through a 100 μm mesh. Cells were washed and, subsequently, viability of cells was determined by trypan blue staining. Two million living cells were seeded on collagen type I-coated 6 cm dishes and harvested after 24 hr. For in vitro inhibition of p38 MAPK, freshly isolated primary hepatocytes were treated with SB203580 (10 μM) or its solvent (DMSO) and harvested after 5 hr.
Protein isolation and Western blot analysis
Preparation of whole cell extracts was done with radioimmunoprecipitation assay buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5% (v/v) sodium deoxylcholate, 1% (v/v) NP-40, proteinase inhibitor cocktail), and purification of Myc-tagged transgenic S100a8/a9 was performed with mammalian cMyc-tag/Co-IP Kit (Pierce) according to the manufacturer’s instructions. Proteins were separated on a 15% SDS-polyacrylamide gel in SDS-sample buffer, transferred to nitrocellulose membrane (Optitran BA-S83) and incubated with specific primary and HRP-labeled secondary antibodies (DakoCytomation). The blots were developed using the Classic E.O.S. developer (Agfa). Primary antibodies are listed in Additional file9 (Table S1).
ELISAs for Cxc11, Cxcl2, G-Csf (all from R&D Systems), and S100A8/A9 (Immundiagnostik AG) were performed according to the manufacturer’s instructions.
Immunohistochemistry and tissue staining
IHC analysis on paraffin sections was performed according to the manufacturer’s instructions (Vector Laboratories), and sections were counterstained with hematoxylin. Primary and secondary antibodies are listed in Additional file9 (Table S1). Stained tissue sections were visualized and photographed using a Leica DMLB microscope and Olympus XC50 camera at a magnitude of 100x. Representative pictures for each genotype are shown.
RNA preparation and quantitative real time polymerase chain reaction
Total RNA extraction was performed according to the manufacturer`s instructions using peqGOLD RNAPure (PeqLab Biotechnology). RNA was reverse transcribed using RevertAid H Minus-MuLV RT (Fermentas) and oligo-dT primers, followed by standard qRT-PCR performed on a detection system (StepOnePlus™; Applied Biosystems) using the Power SYBR® Green PCR Master Mix (Applied Biosystems). Quantitative real-time polymerase chain reaction (qRT-PCR) analysis was performed as described previously. Primers used for qRT-PCR analysis are listed in Additional file10 (Table S2). Target gene cycle of threshold values were normalized to the corresponding cycle of threshold values of Hprt using the change in cycle of threshold method.
Preparation of blood samples and flow cytometry
For detection of immune subpopulations in peripheral blood, whole blood samples were mixed with EDTA (final 5 mM), subjected to erythrocyte lysis (ACK buffer, Lonza) and subsequently blockade of Fc-receptors (anti-Cd16/32, eBioscience). Staining was performed at 4°C for 30 min and cells were determined by flow cytometry analysis in FACSCalibur (BD Bioscience) using the software FlowJo (Tree Star, Inc.). Antibodies are listed in Additional file9 (Table S1). As positive control for Cd11b upregulation and L-Selectin shedding, peripheral blood cells were treated with 10 μg/ml TPA for 5 min and stained as described.
Digital images and statistical analysis
Digital images were elaborated using Photoshop CS3 (Adobe); the luminosity of brightest and dimmest pixel in each channel were adjusted to obtain the best visual reproduction, taking care to maintain linearity in the brightness scale. Error bars represent SD except were indicated. Statistical evaluation of obtained data was performed with SigmaPlot 11.0 (Systat Software Inc.).
Cluster of differentiation
C-X-C motif ligand
C-X-C motif receptor
Enzyme-linked absorbent immunoassay
Granulocyte colony-stimulatory factor
Granulocyte macrophage colony-stimulating factor
Hematoxylin and eosin
Intercellular adhesion molecule
Liver activator protein 1
Lymphocyte antigen 6
Macrophage colony-stimulating factor
Multidrug resistance 2
Myeloid derived suppressor cells
Nicotinamid adenosine dinucleotide phosphate
Quantitative real-time PCR
Reactive oxygen species
Hepatocyte-specific S100a8/a9 transgenic mouse
Tumor necrosis factor
We thank Angelika Krischke for excellent technical support and Julia Leibold for helpful discussion. This work was supported by the Cooperation in Cancer Research of the German Cancer Research Center and Israeli Ministry of Science, Culture and Sport (Ca-130 to PA, and JH, and Ca-147 to PA), the German Research Foundation (SFB Transregio 77, to SMar, AV, PA, and JH), the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Systems Biology (to PA and JH), the Federal Ministry of Science, Education and Art (MWK Excellence Cluster Initiative to PA and JH), the Foundation Tumorforschung Kopf-Hals e.V. (to JH), and the ‘Virtual Liver’ funding initiative of the German Federal Ministry of Education and Research (BMBF) (to SMan and UK).
- Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001, 33: 637-668. 10.1016/S1357-2725(01)00046-2.View ArticlePubMedGoogle Scholar
- Dale I, Fagerhol MK, Naesgaard I: Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem. 1983, 134: 1-6. 10.1111/j.1432-1033.1983.tb07522.x.View ArticlePubMedGoogle Scholar
- Odink K, Cerletti N, Bruggen J, Clerc RG, Tarcsay L, Zwadlo G, Gerhards G, Schlegel R, Sorg C: Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature. 1987, 330: 80-82. 10.1038/330080a0.View ArticlePubMedGoogle Scholar
- Teigelkamp S, Bhardwaj RS, Roth J, Meinardus-Hager G, Karas M, Sorg C: Calcium-dependent complex assembly of the myeloic differentiation proteins MRP-8 and MRP-14. J Biol Chem. 1991, 266: 13462-13467.PubMedGoogle Scholar
- Lagasse E, Weissman IL: Mouse MRP8 and MRP14, two intracellular calcium-binding proteins associated with the development of the myeloid lineage. Blood. 1992, 79: 1907-1915.PubMedGoogle Scholar
- Curran CS, Bertics PJ: Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B. Int Immunol. 2011, 23: 713-728. 10.1093/intimm/dxr083.PubMed CentralView ArticlePubMedGoogle Scholar
- Srikrishna G: S100A8 and S100A9: new insights into their roles in malignancy. J Innate Immun. 2012, 4: 31-40. 10.1159/000330095.View ArticlePubMedGoogle Scholar
- Gebhardt C, Nemeth J, Angel P, Hess J: S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol. 2006, 72: 1622-1631. 10.1016/j.bcp.2006.05.017.View ArticlePubMedGoogle Scholar
- Vogl T, Ludwig S, Goebeler M, Strey A, Thorey IS, Reichelt R, Foell D, Gerke V, Manitz MP, Nacken W: MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood. 2004, 104: 4260-4268. 10.1182/blood-2004-02-0446.View ArticlePubMedGoogle Scholar
- Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, Gunzer M, Frings W, Schonlau F, Roth J, Sorg C, Nacken W: Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol. 2003, 23: 1034-1043. 10.1128/MCB.23.3.1034-1043.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Newton RA, Hogg N: The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol. 1998, 160: 1427-1435.PubMedGoogle Scholar
- Kerkhoff C, Nacken W, Benedyk M, Dagher MC, Sopalla C, Doussiere J: The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2. FASEB J. 2005, 19: 467-469.PubMedGoogle Scholar
- Benedyk M, Sopalla C, Nacken W, Bode G, Melkonyan H, Banfi B, Kerkhoff C: HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-kappaB activities. J Invest Dermatol. 2007, 127: 2001-2011. 10.1038/sj.jid.5700820.View ArticlePubMedGoogle Scholar
- Lackmann M, Rajasekariah P, Iismaa SE, Jones G, Cornish CJ, Hu S, Simpson RJ, Moritz RL, Geczy CL: Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10. J Immunol. 1993, 150: 2981-2991.PubMedGoogle Scholar
- Nukui T, Ehama R, Sakaguchi M, Sonegawa H, Katagiri C, Hibino T, Huh NH: S100A8/A9, a key mediator for positive feedback growth stimulation of normal human keratinocytes. J Cell Biochem. 2008, 104: 453-464. 10.1002/jcb.21639.View ArticlePubMedGoogle Scholar
- Hiratsuka S, Watanabe A, Aburatani H, Maru Y: Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol. 2006, 8: 1369-1375. 10.1038/ncb1507.View ArticlePubMedGoogle Scholar
- Hiratsuka S, Watanabe A, Sakurai Y, Akashi-Takamura S, Ishibashi S, Miyake K, Shibuya M, Akira S, Aburatani H, Maru Y: The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol. 2008, 10: 1349-1355. 10.1038/ncb1794.View ArticlePubMedGoogle Scholar
- van Lent PL, Grevers L, Blom AB, Sloetjes A, Mort JS, Vogl T, Nacken W, van den Berg WB, Roth J: Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis. 2008, 67: 1750-1758. 10.1136/ard.2007.077800.View ArticlePubMedGoogle Scholar
- Ichikawa M, Williams R, Wang L, Vogl T, Srikrishna G: S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res. 2011, 9: 133-148. 10.1158/1541-7786.MCR-10-0394.PubMed CentralView ArticlePubMedGoogle Scholar
- Arai K, Yamada T, Nozawa R: Immunohistochemical investigation of migration inhibitory factor-related protein (MRP)-14 expression in hepatocellular carcinoma. Med Oncol. 2000, 17: 183-188. 10.1007/BF02780526.View ArticlePubMedGoogle Scholar
- Nemeth J, Stein I, Haag D, Riehl A, Longerich T, Horwitz E, Breuhahn K, Gebhardt C, Schirmacher P, Hahn M: S100A8 and S100A9 are novel NF-kB target genes during malignant progression of murine and human liver carcinogenesis. Hepatology. 2009, 50: 1251-1262. 10.1002/hep.23099.View ArticlePubMedGoogle Scholar
- Chiba M, Murata S, Myronovych A, Kohno K, Hiraiwa N, Nishibori M, Yasue H, Ohkohchi N: Elevation and characteristics of Rab30 and S100a8/S100a9 expression in an early phase of liver regeneration in the mouse. Int J Mol Med. 2011, 27: 567-574.PubMedGoogle Scholar
- Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA: Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol. 2003, 170: 3233-3242.View ArticlePubMedGoogle Scholar
- Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, Tessier PA: Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol. 2003, 171: 2602-2609.View ArticlePubMedGoogle Scholar
- Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, Lubbert H, Bujard H: Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A. 1996, 93: 10933-10938. 10.1073/pnas.93.20.10933.PubMed CentralView ArticlePubMedGoogle Scholar
- Hu SP, Harrison C, Xu K, Cornish CJ, Geczy CL: Induction of the chemotactic S100 protein, CP-10, in monocyte/macrophages by lipopolysaccharide. Blood. 1996, 87: 3919-3928.PubMedGoogle Scholar
- Lagasse E, Clerc RG: Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol Cell Biol. 1988, 8: 2402-2410.PubMed CentralView ArticlePubMedGoogle Scholar
- Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE: Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol. 2008, 83: 64-70.View ArticlePubMedGoogle Scholar
- Carr KD, Sieve AN, Indramohan M, Break TJ, Lee S, Berg RE: Specific depletion reveals a novel role for neutrophil-mediated protection in the liver during Listeria monocytogenes infection. Eur J Immunol. 2011, 41: 2666-2676. 10.1002/eji.201041363.PubMed CentralView ArticlePubMedGoogle Scholar
- Youn JI, Nagaraj S, Collazo M, Gabrilovich DI: Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol. 2008, 181: 5791-5802.PubMed CentralView ArticlePubMedGoogle Scholar
- Bajt ML, Farhood A, Jaeschke H: Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature. Am J Physiol Gastrointest Liver Physiol. 2001, 281: G1188-1195.PubMedGoogle Scholar
- Furze RC, Rankin SM: Neutrophil mobilization and clearance in the bone marrow. Immunology. 2008, 125: 281-288. 10.1111/j.1365-2567.2008.02950.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Eash KJ, Greenbaum AM, Gopalan PK, Link DC: CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest. 2010, 120: 2423-2431. 10.1172/JCI41649.PubMed CentralView ArticlePubMedGoogle Scholar
- Martin C, Burdon PC, Bridger G, Gutierrez-Ramos JC, Williams TJ, Rankin SM: Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity. 2003, 19: 583-593. 10.1016/S1074-7613(03)00263-2.View ArticlePubMedGoogle Scholar
- Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144: 646-674. 10.1016/j.cell.2011.02.013.View ArticlePubMedGoogle Scholar
- Peters AM, Saverymuttu SH, Keshavarzian A, Bell RN, Lavender JP: Splenic pooling of granulocytes. Clin Sci (Lond). 1985, 68: 283-289.View ArticleGoogle Scholar
- Sadik CD, Kim ND, Luster AD: Neutrophils cascading their way to inflammation. Trends Immunol. 2011, 32: 452-460. 10.1016/j.it.2011.06.008.PubMed CentralView ArticlePubMedGoogle Scholar
- Mann BS, Chung KF: Blood neutrophil activation markers in severe asthma: lack of inhibition by prednisolone therapy. Respir Res. 2006, 7: 59-10.1186/1465-9921-7-59.PubMed CentralView ArticlePubMedGoogle Scholar
- Cornish CJ, Devery JM, Poronnik P, Lackmann M, Cook DI, Geczy CL: S100 protein CP-10 stimulates myeloid cell chemotaxis without activation. J Cell Physiol. 1996, 166: 427-437. 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6.View ArticlePubMedGoogle Scholar
- Burdon PC, Martin C, Rankin SM: Migration across the sinusoidal endothelium regulates neutrophil mobilization in response to ELR + CXC chemokines. Br J Haematol. 2008, 142: 100-108. 10.1111/j.1365-2141.2008.07018.x.View ArticlePubMedGoogle Scholar
- von Vietinghoff S, Ley K: Homeostatic regulation of blood neutrophil counts. J Immunol. 2008, 181: 5183-5188.PubMed CentralView ArticlePubMedGoogle Scholar
- Wengner AM, Pitchford SC, Furze RC, Rankin SM: The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation. Blood. 2008, 111: 42-49. 10.1182/blood-2007-07-099648.PubMed CentralView ArticlePubMedGoogle Scholar
- Wiekowski MT, Chen SC, Zalamea P, Wilburn BP, Kinsley DJ, Sharif WW, Jensen KK, Hedrick JA, Manfra D, Lira SA: Disruption of neutrophil migration in a conditional transgenic model: evidence for CXCR2 desensitization in vivo. J Immunol. 2001, 167: 7102-7110.View ArticlePubMedGoogle Scholar
- Wang H, Gao X, Fukumoto S, Tademoto S, Sato K, Hirai K: Differential expression and regulation of chemokines JE, KC, and IP-10 gene in primary cultured murine hepatocytes. J Cell Physiol. 1999, 181: 361-370. 10.1002/(SICI)1097-4652(199911)181:2<361::AID-JCP18>3.0.CO;2-9.View ArticlePubMedGoogle Scholar
- Orlichenko LS, Behari J, Yeh TH, Liu S, Stolz DB, Saluja AK, Singh VP: Transcriptional regulation of CXC-ELR chemokines KC and MIP-2 in mouse pancreatic acini. Am J Physiol Gastrointest Liver Physiol. 2010, 299: G867-876. 10.1152/ajpgi.00177.2010.PubMed CentralView ArticlePubMedGoogle Scholar
- Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, Muller M, Blander JM, Tacke F, Trautwein C: Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med. 2010, 207: 1453-1464. 10.1084/jem.20091474.PubMed CentralView ArticlePubMedGoogle Scholar
- Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, Roth J: Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med. 2007, 13: 1042-1049. 10.1038/nm1638.View ArticlePubMedGoogle Scholar
- Riehl A, Nemeth J, Angel P, Hess J: The receptor RAGE: Bridging inflammation and cancer. Cell Commun Signal. 2009, 7: 12-10.1186/1478-811X-7-12.PubMed CentralView ArticlePubMedGoogle Scholar
- Datta S, Biswas R, Novotny M, Pavicic PG, Herjan T, Mandal P, Hamilton TA: Tristetraprolin regulates CXCL1 (KC) mRNA stability. J Immunol. 2008, 180: 2545-2552.View ArticlePubMedGoogle Scholar
- Yang HT, Cohen P, Rousseau S: IL-1beta-stimulated activation of ERK1/2 and p38alpha MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-alpha in HeLa cells. Cell Signal. 2008, 20: 375-380. 10.1016/j.cellsig.2007.10.025.View ArticlePubMedGoogle Scholar
- Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D: S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res. 2006, 312: 184-197. 10.1016/j.yexcr.2005.10.013.View ArticlePubMedGoogle Scholar
- Klingmuller U, Bauer A, Bohl S, Nickel PJ, Breitkopf K, Dooley S, Zellmer S, Kern C, Merfort I, Sparna T: Primary mouse hepatocytes for systems biology approaches: a standardized in vitro system for modelling of signal transduction pathways. Syst Biol (Stevenage). 2006, 153: 433-447. 10.1049/ip-syb:20050067.View ArticleGoogle Scholar
- Gebhardt C, Riehl A, Durchdewald M, Nemeth J, Furstenberger G, Muller-Decker K, Enk A, Arnold B, Bierhaus A, Nawroth PP: RAGE signaling sustains inflammation and promotes tumor development. J Exp Med. 2008, 205: 275-285. 10.1084/jem.20070679.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.